PPD uses cookies on this website. Please be aware that if you continue browsing the website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Pregnancy Registries and Infant Follow-up Studies

PPD is a leading global provider of pregnancy registries and other study methodologies to assess the effects of exposure to medicinal products during pregnancy. We provide consultation, design, implementation, analysis, interpretation and dissemination services, including:

Pregnancy registries and infant follow-up studies

Case control studies

Database studies (linked medication, obstetric and pediatric data)

Study design, protocol and case report form development services

Negotiations with regulatory agencies

Establishment and facilitation of advisory committees

Registry/study implementation and project management

Recruitment and retention plans

Signal detection, endpoint evaluation and adjudication

Study reports, scientific manuscripts and abstracts

Extensive Experience in Pregnancy Studies

Studies that evaluate the safety of medicinal products when used during pregnancy face unique challenges, such as achieving an adequate sample size, limited data availability, multiple data sources and identification of appropriate comparator groups. PPD overcomes these challenges through our:

Experience developing and implementing pregnancy studies that meet regulatory agency requirements in a wide range of therapeutic areas since 1997

Thought leaders who have served as invited consultants to the World Health Organization, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC) and who have published or presented more than 50 papers on best practices concerning pregnancy registries